Related by context. All words. (Click for frequent words.) 71 chemotherapy regimens 70 regimens 68 antiretroviral regimens 67 therapeutic regimens 67 HAART regimen 66 chemotherapies 65 antiviral therapy 64 therapies 64 HAART regimens 63 dosing regimens 63 chemotherapy regimen 61 ribavirin therapy 61 interferon ribavirin 61 chemotherapeutic regimens 61 dosing schedules 61 protease inhibitor PI 61 dose regimen 61 antibiotic therapy 60 interferon therapy 60 treatments 60 antidepressant therapy 60 antihypertensive therapy 60 medication regimens 60 ribavirin RBV 60 dose regimens 60 antibiotic regimens 60 cytotoxic therapy 59 DMARD therapy 59 immunosuppressive regimens 59 trastuzumab Herceptin ® 59 dosage regimens 59 pegylated interferon 59 standard chemotherapy regimens 59 GnRH agonists 59 antiretroviral therapy 59 antiretroviral regimen 58 adverse cytogenetics 58 mRCC 58 cytotoxic chemotherapy 58 antiretroviral therapies 58 lipid lowering therapies 58 docetaxel chemotherapy 58 hormonal therapies 58 DMARDs 58 gemcitabine 58 bisphosphonate therapy 58 imatinib therapy 58 dosing regimen 58 mycophenolate mofetil 58 peginterferon 58 adjuvant therapy 58 oral anticoagulants 58 disease modifying antirheumatic 58 gemcitabine Gemzar 58 hormonal therapy 58 nevirapine Viramune 58 NRTIs 58 pegylated interferon alfa 57 warfarin therapy 57 dosing 57 topotecan 57 stavudine d4T 57 sunitinib 57 immunosuppressive agents 57 antiplatelet therapy 57 mealtime insulin 57 therapies ACTs 57 NNRTIs 57 virologic failure 57 immunosuppressive therapies 57 cART 57 HAART 57 rituximab 57 boosted protease inhibitor 57 antimicrobial prophylaxis 57 antiretroviral therapy ART 57 ribavirin 57 temozolomide 57 chemoradiation 56 NNRTI 56 corticosteroid therapy 56 immunosuppressant therapy 56 stavudine 56 idarubicin 56 peg IFN 56 isoniazid 56 β blockers 56 TNF inhibitor 56 chronic HCV 56 Hydroxyurea 56 immunomodulatory therapy 56 PegIFN RBV 56 lupus nephritis 56 aromatase inhibitor therapy 56 dasatinib 56 dosage regimen 56 statin therapy 56 uric acid lowering 56 mitoxantrone 56 protease inhibitors 56 invasive aspergillosis 56 regimen 56 relapsed AML 56 combination antiretroviral therapy 56 pyrazinamide 56 neurologic progression 56 VICTRELIS 56 docetaxel 56 lamivudine 56 chemotherapeutic agents 56 amoxicillin clavulanate 56 tipranavir 56 pyridostigmine 56 virological failure 56 interferon 56 biologic therapy 56 trastuzumab 56 iron chelation therapy 56 anticancer therapies 56 imatinib Gleevec 56 adalimumab Humira 56 interferon alfa 56 invasive candidiasis 56 ARV regimens 56 leukotriene receptor antagonist 56 intravenous bisphosphonates 56 warfarin 56 Combination therapy 56 antiplatelet drugs 56 levodopa therapy 56 pegfilgrastim 55 TNF inhibitors 55 phosphate binders 55 antihypertensive medications 55 anti TNF 55 antiplatelet agents 55 hepatitis C genotype 55 Doxil ® 55 bevacizumab Avastin 55 antihypertensive drugs 55 chronic HCV infection 55 standard chemotherapy regimen 55 leucovorin 55 personalized immunotherapy 55 Ribavirin 55 peginterferon alfa 2a 55 APTIVUS r 55 chlorambucil 55 infliximab 55 infliximab Remicade 55 aldosterone antagonist 55 immunosuppression 55 antiemetics 55 imatinib 55 alkylating agent 55 antiretroviral medications 55 lapatinib Tykerb 55 irinotecan 55 lipid lowering therapy 55 ritonavir boosted 55 superficial bladder cancer 55 TMP SMX 55 PREZISTA r 55 candidemia 55 dexamethasone Decadron 55 APTIVUS 55 antiviral therapies 55 antidiabetic therapy 55 inhaled corticosteroids 55 thromboprophylaxis 55 anticoagulation therapy 55 azathioprine 55 glucose lowering 55 coinfected patients 55 5 FU 55 ganciclovir 55 pertuzumab 55 relapsed ovarian cancer 55 palliative radiotherapy 55 achieve sustained virologic 55 ART regimens 55 Revlimid lenalidomide 55 NRTI 55 chemotherapy docetaxel 55 cetuximab 55 dose cytarabine 54 anti angiogenic agents 54 levosimendan 54 PREZISTA rtv 54 cytoreduction 54 INTELENCE 54 tamoxifen therapy 54 ceftriaxone 54 dosing frequency 54 monotherapy 54 preoperative chemotherapy 54 TKIs 54 nilotinib 54 recurrent GBM 54 dasatinib Sprycel 54 adjuvant chemotherapy 54 intravenous cyclophosphamide 54 pegylated interferon alfa 2a 54 disease progression 54 calcineurin inhibitors 54 salmeterol fluticasone 54 fulvestrant 54 paricalcitol 54 immunosuppressive medications 54 chemotherapeutic regimen 54 adjuvant tamoxifen 54 paclitaxel Taxol 54 anticlotting drugs 54 vandetanib 54 MyVax R 54 bevacizumab Avastin ® 54 nitazoxanide 54 darunavir 54 KAPIDEX 54 entecavir 54 forodesine 54 sulfadoxine pyrimethamine 54 amphotericin B 54 HSCT 54 LTRA 54 sorafenib Nexavar 54 monotherapies 54 methotrexate therapy 54 HCV genotype 1 54 fluorouracil 54 empiric therapy 54 relapsing MS 54 dalteparin 54 TRV# [001] 54 pharmacotherapies 54 chemotherapeutic drugs 54 warfarin dosage 54 alfa 2a 54 enfuvirtide 54 heavily pretreated patients 54 5 fluorouracil 54 irinotecan chemotherapy 54 antiplatelet therapies 54 NSAID therapy 54 caspofungin 54 antifungal therapy 54 efavirenz Sustiva 54 chemotherapeutics 54 heavily pretreated 54 refractory CLL 54 methotrexate 54 antihypertensive agents 54 antiretroviral naïve 54 Dabigatran 54 tolerability 54 Adjuvant chemotherapy 54 mapatumumab 54 erlotinib Tarceva ® 54 micafungin 54 AZT zidovudine Retrovir 54 sotalol 54 Sunitinib 54 fludarabine 54 AGILECT R 54 Copegus ribavirin 54 bortezomib 54 antidiabetic drugs 54 azacitidine 54 therapeutic interventions 54 lenalidomide Revlimid R 54 docetaxel Taxotere ® 54 inhaled bronchodilators 54 FOLFIRI 53 DMARD 53 inhaled steroids 53 IV bisphosphonates 53 atypicals 53 chemotherapy 53 daptomycin 53 adjuvant therapies 53 decitabine 53 anti retroviral therapies 53 Peg IFN 53 pomalidomide 53 adalimumab 53 somatostatin analogues 53 direct thrombin inhibitors 53 bendamustine 53 CTAP# Capsules 53 curative therapy 53 refractory chronic myeloid 53 dose escalation 53 CHOP chemotherapy 53 pegylated liposomal doxorubicin 53 carboplatin paclitaxel 53 tyrosine kinase inhibitors TKIs 53 OHR/AVR# 53 MYCAMINE 53 anticancer treatments 53 antiepileptic medications 53 monoclonal antibody therapies 53 pimozide 53 posaconazole 53 antibiotic prophylaxis 53 potent antiretroviral therapy 53 paclitaxel Taxol ® 53 HCV protease inhibitors 53 cytoreductive surgery 53 Dasatinib 53 boceprevir 53 lenalidomide dexamethasone 53 Taxotere 53 trabectedin 53 acid suppressing 53 Pegasys peginterferon alfa 2a 53 TroVax ® 53 taxane therapy 53 NSTE ACS 53 etoposide 53 pazopanib 53 Fludara 53 Gleevec imatinib 53 dopaminergic therapy 53 pharmacotherapy 53 5FU 53 pegylated interferon alpha 53 cefepime 53 HCV RESPOND 2 53 gemcitabine carboplatin 53 PEGINTRON 53 Torisel 53 intensive statin therapy 53 NCCN Guidelines ™ 53 differentiated thyroid 53 biologic DMARDs 53 inhibitor RG# 53 Isentress raltegravir 53 ofpatients 53 antiplatelet medication 53 temsirolimus 53 LDL lowering 53 mycophenolate mofetil MMF 53 rifapentine 53 allopurinol 53 genotypic resistance 53 chlorthalidone 53 CANCIDAS 53 L dopa 53 TKI therapy 53 pharmacologic treatments 53 visilizumab 53 integrase inhibitor 53 raltegravir 53 carvedilol 53 nucleoside analogs 53 nucleoside analogues 53 hepatic metastases 53 oral anticoagulation 53 protease inhibitor 53 concomitant medications 53 warfarin dosing 53 herpes zoster vaccine 53 viral suppression 53 rosuvastatin Crestor 53 chemoradiotherapy 53 pentoxifylline 53 enzastaurin 53 trimethoprim sulfamethoxazole 53 tigecycline 53 antithrombotic therapy 53 Velcade bortezomib 53 zidovudine lamivudine 53 DAPT 53 interferon alfa 2b 53 topical retinoids 53 immunotherapy 53 gemifloxacin 53 dasatinib Sprycel ® 53 dual antiplatelet therapy 53 oral deforolimus 53 erlotinib Tarceva 53 opioid analgesia 53 sorafenib 53 intrathecal chemotherapy 53 external beam radiotherapy 53 antiangiogenic therapy 53 virological suppression 53 sustained virologic response 53 hemodialysis patients 53 systemic corticosteroids 53 bronchodilators 53 tolvaptan 53 dirucotide MBP# 53 trastuzumab Herceptin 53 antithrombotic 53 Bacillus Calmette Guerin BCG 53 eflornithine 53 immunomodulators 53 Phase IIb trials 53 statin medications 53 tyrosine kinase inhibitors 53 relapsed CLL 53 quinidine 53 oral antidiabetes drugs 53 gefitinib Iressa 53 EGFR tyrosine kinase inhibitors 53 abiraterone 53 carboplatin 53 empiric treatment 53 androgen ablation 53 toxicities 53 COPD exacerbations 53 intravesical therapy 53 tamoxifen 53 dacarbazine 53 BEACOPP 53 Fludarabine 52 Enbrel Humira 52 beta agonists 52 dietary regimens 52 anti leukemic 52 APTIVUS ritonavir 52 DMARDS 52 NCCN guidelines 52 ADHF 52 chronic GVHD 52 overlapping toxicities 52 Novartis Gleevec 52 NATRECOR R 52 ARV therapy 52 cabazitaxel 52 therapy 52 biologic DMARD 52 pharmacologic intervention 52 anticoagulation 52 antiarrhythmic drug 52 antiarrhythmic drugs 52 oral NSAIDs 52 tuberculin skin testing 52 alkylating agents 52 tamoxifen Nolvadex ® 52 pharmacological treatments 52 gonococcal infections 52 anticancer therapy 52 anticoagulants 52 Quetiapine 52 cisplatin 52 peg interferon 52 co trimoxazole 52 abacavir lamivudine 52 inhaled corticosteroid therapy 52 daunorubicin 52 cidofovir 52 intravenous diuretics 52 refractory angina 52 hyperphosphataemia 52 paclitaxel Taxol R 52 virologic suppression 52 quinolone 52 HBeAg negative 52 nelfinavir 52 plus ribavirin 52 agomelatine 52 anthracyclines taxanes 52 interferon injections 52 dosing interval 52 induce remission 52 TNF antagonist 52 anakinra 52 taxanes 52 KRAS status 52 beta interferon 52 EGFR antibodies 52 antihypertensive medication 52 xanthine oxidase inhibitor 52 therapeutic modalities 52 cytotoxic agents 52 Mitoxantrone 52 vicriviroc 52 interferon alpha injections 52 TNF alpha inhibitor 52 rt PA 52 dose cohorts 52 trials RCTs 52 randomized trials 52 docetaxel Taxotere 52 leukemia AML 52 antiplatelet medications 52 tofacitinib 52 aripiprazole Abilify 52 proteasome inhibitors 52 PROLARIS 52 KRAS mutant tumors 52 Symadex 52 Retreatment 52 curative resection 52 Pegasys ® 52 AMN# [001] 52 androgen deprivation 52 prophylactic antibiotics 52 revascularization procedures 52 patients 52 chemotherapeutic 52 Merck Isentress 52 metastatic renal cell carcinoma 52 inhaled glucocorticoids 52 viral kinetics 52 indolent NHL 52 COMBIVIR 52 H. pylori eradication 52 pegylated interferon alfa 2b 52 LMWH 52 recurrent genital herpes 52 pegylated interferons 52 metastatic malignant melanoma 52 letrozole Femara 52 voriconazole 52 cyclophosphamide 52 colorectal cancer liver metastases 52 FOSRENOL ® 52 metastatic kidney 52 co morbidities 52 ethambutol 52 Liver transplantation 52 clinical trials 52 anti TNFs 52 HCV infection 52 antiangiogenic agents 52 thrombolytic agents 52 ixabepilone 52 hyperphosphatemia 52 somatostatin analogs 52 Pegylated Interferon 52 prophylactic therapy 52 insulin detemir 52 subcutaneous injections 52 hydroxychloroquine 52 tolerability profile 52 metastatic RCC 52 antianginal 52 non selective NSAIDs 52 5-FU/LV 52 lipid lowering agents 52 verteporfin 52 ARV regimen 52 VAPRISOL 52 EGFR inhibitors 52 antiepileptics 52 MMP inhibitors 52 deferiprone 52 anthracycline 52 Dacogen injection 52 Mylotarg 52 antiepileptic drugs 52 Sustiva efavirenz 52 immunosuppressive regimen 52 chronic hepatitis C 52 tolterodine 52 Instanyl 52 pharmacological approaches 52 intravesical 52 metastatic bone 52 NRTI backbone 52 HRPC 52 fluvastatin 52 disease modifying 52 MDS AML 52 thiazide diuretic 52 zidovudine AZT 52 mitochondrial toxicity 52 predictive biomarkers 52 Navelbine ® 52 lipid lowering medication 52 hereditary deficiency 52 nonsurgical treatments 52 platelet inhibitor 52 Cytarabine 52 iron chelation 52 metformin 52 LHRH antagonists 52 NATRECOR ® 52 glycemia 52 dose titration 52 Cloretazine 52 imipenem 52 ISENTRESS 52 brain metastases 52 Isentress 51 phosphate binder therapy 51 amodiaquine 51 anidulafungin 51 unfractionated heparin 51 idraparinux 51 glitazones 51 thalidomide Thalomid 51 acute STEMI 51 relapsed MM 51 serum phosphorus levels 51 recurrent glioblastoma multiforme 51 ICD implantation 51 iclaprim 51 metastatic hormone refractory 51 cytarabine 51 ciclosporin 51 Telintra 51 tyrosine kinase inhibitor TKI 51 cisplatin chemotherapy 51 atazanavir 51 interpersonal psychotherapy 51 nucleoside analogue 51 LABAs 51 abiraterone acetate 51 basal insulin 51 Tarceva erlotinib 51 metformin sulphonylurea 51 d4T 51 clozapine 51 medications 51 panitumumab 51 Kantarjian 51 rituximab Rituxan 51 MAO inhibitors 51 metastatic colorectal cancer 51 tolerability profiles 51 clopidogrel Plavix 51 pharmacological therapy 51 paroxysmal AF 51 anti coagulant therapy 51 hypomethylating agents 51 tenofovir Viread 51 rifamycins 51 primary hypercholesterolemia 51 Vectibix 51 dose colchicine 51 treating neuropathic pain 51 REMICADE ® 51 myopathy rhabdomyolysis 51 ritonavir boosted lopinavir 51 protease inhibitors PIs 51 dapsone 51 LHRH analogues 51 HCV SPRINT 51 mitomycin 51 antithrombotics 51 cilengitide 51 d4T stavudine Zerit 51 FOLFIRINOX 51 interferon alpha 51 ancrod 51 null responder HCV 51 darbepoetin alfa Aranesp 51 rituximab refractory 51 drugs DMARDs 51 paliperidone palmitate 51 DOXIL 51 aspirin clopidogrel 51 KRAS mutations occur 51 Oxaliplatin 51 pharmacologic therapy 51 antiretroviral treatments 51 FOLFOX 51 IRX 2 51 EGFRIs 51 Zytiga 51 relapsed SCLC 51 cyclophosphamide Cytoxan 51 pharmacokinetic interactions 51 ICD therapy 51 immunosuppressive drugs 51 TNF therapy 51 cardiac toxicity 51 pramlintide 51 montelukast 51 trans retinoic acid ATRA 51 elotuzumab 51 tenofovir emtricitabine 51 dosages 51 intravenous antibiotic 51 Edurant 51 radioiodine therapy 51 typical antipsychotics 51 relapsed ALL 51 N acetylcysteine 51 Gleevec resistant 51 immunosuppressives 51 bosentan 51 cisplatin carboplatin 51 anti tubercular 51 mixed hyperlipidemia 51 CAELYX 51 prostate cancer CRPC 51 fibrinolytic 51 peginterferon alfa 51 thromboembolic disease 51 rituximab Rituxan ® 51 immunosuppressant 51 pramlintide metreleptin combination 51 canakinumab 51 imatinib mesylate Gleevec 51 vinorelbine 51 long acting bronchodilator 51 signal transduction inhibitors 51 HCV 51 etravirine 51 Xelox 51 conventional antipsychotics 51 initiating antiretroviral therapy 51 certolizumab 51 dexpramipexole 51 EGFR TKIs 51 COPAXONE R 51 anticonvulsant medications 51 clinical pharmacology studies 51 ritonavir boosted protease inhibitor 51 chemo radiotherapy 51 GP IIb IIIa inhibitors 51 alpha interferon 51 nucleoside 51 HBeAg positive patients 51 dosing intervals 51 immunotherapies 51 candesartan 51 intravenous chemotherapy 51 oxaliplatin 51 levodopa carbidopa 51 gliclazide 51 spironolactone 51 anthracycline therapy 51 transplantation HCT 51 taxane 51 PEG Intron 51 sipuleucel T 51 nosocomial pneumonia 51 cediranib 51 Epivir 51 antitumor effect 51 placebo controlled studies 51 CCyR 51 antiretroviral naive 51 pegylated interferon peg IFN 51 nab paclitaxel 51 LY# [003] 51 lamivudine 3TC 51 TACE 51 intra arterial chemotherapy 51 anthracycline containing 51 gefitinib 51 daclizumab 51 nephrotoxicity 51 oral rivaroxaban 51 6 mercaptopurine 51 relapsed refractory 51 SPRYCEL 51 stable angina 51 corticosteroids 51 hydroxyurea 51 panobinostat 51 steroid inhalers 51 macrovascular events 51 paclitaxel 51 ZYVOX 51 nucleotide analogue 51 Anthracycline 51 doxorubicin docetaxel 51 Cisplatin 51 FOLFOX6 51 INCB# [001] 51 MULTAQ 51 amiodarone 51 otelixizumab 51 APTIVUS R 51 cyclosporin 51 allogeneic HSCT 51 postexposure prophylaxis 51 Abiraterone acetate 51 oral antidiabetic agents 51 Allovectin 7 ® 51 AZILECT ® 51 bolus dose 51 statin 51 sulphonylureas 51 Rifampin 51 nucleoside reverse transcriptase inhibitor 51 taxane chemotherapy 51 glatiramer acetate 51 comorbidities 51 chronic hemodialysis 51 Therapy HAART 51 TELINTRA 51 aldosterone antagonists 51 warfarin anticoagulation 51 TMC# [001] 51 cardiotoxicity 51 risperidone Risperdal 51 Inhaled insulin 51 BeneFIX 51 panitumumab Vectibix 51 sulfasalazine 51 Amigal 51 Dose adjustments 51 HER2 positive metastatic breast 51 HCV infected 51 regorafenib 50 diabetic gastroparesis 50 ascending doses 50 bexarotene 50 MyVax ® 50 Neulasta ® 50 ATACAND 50 oral anticoagulant therapy 50 antiandrogens 50 oral diclofenac 50 dietary modification 50 abatacept 50 trivalent vaccine 50 leukotriene receptor antagonists 50 liposomal doxorubicin 50 IFN beta 50 nucleoside reverse transcriptase inhibitors 50 antiretrovirals 50 fibrate drugs 50 prior chemotherapy regimens 50 DCVax ® Brain 50 Intravenous CP 50 pegylated alpha interferon 50 inactivated influenza vaccines 50 Fludara ® 50 Gleevec imatinib mesylate 50 macrolide antibiotics 50 beta blocker therapy 50 Bortezomib 50 atovaquone 50 lopinavir r 50 polysaccharide vaccines 50 CYT# potent vascular disrupting 50 T2DM 50 fosamprenavir 50 systemic immunosuppressive drugs 50 oxymorphone ER 50 taxotere 50 IVIG therapy 50 low dose cytarabine 50 tyrosine kinase inhibitor 50 nonpharmacologic 50 exemestane Aromasin 50 mTOR inhibitors 50 Trevor Mundel MD 50 pimecrolimus 50 nicardipine 50 Renal Cell Carcinoma RCC 50 alpha interferons 50 immunomodulatory 50 sitagliptin 50 debulking surgery 50 smoking cessation therapies 50 advanced NSCLC 50 CsA 50 levodopa 50 apricitabine 50 hemoglobin A1c levels 50 gabapentin Neurontin 50 imatinib resistant 50 MGd 50 LHRH agonists 50 pegylated IFN 50 anthracyclines 50 TNF inhibitor therapy 50 placebo controlled clinical trials 50 preventer inhalers 50 long acting bronchodilators 50 prophylaxis 50 anticoagulant warfarin 50 olmesartan 50 cranial radiation 50 IRESSA 50 anti angiogenic drugs 50 resynchronization therapy 50 elvitegravir 50 maraviroc 50 HGS# 50 SCIg 50 cinacalcet 50 curative treatments 50 Cytoxan 50 SHPT 50 microwave hyperthermia 50 radiation therapy SBRT 50 gemcitabine chemotherapy 50 lapatinib 50 oral antifungal 50 TNF alpha antagonist 50 adefovir 50 PEGINTRON TM 50 riociguat 50 Surgical resection 50 cytarabine daunorubicin 50 Noxafil 50 nesiritide 50 non squamous NSCLC 50 colectomy 50 VTE prophylaxis 50 psychotherapeutic interventions 50 drug DMARD 50 valacyclovir Valtrex 50 Azathioprine 50 Corticosteroids 50 opioid therapy 50 peginterferon alfa 2b 50 Moxifloxacin 50 LDL cholesterol lowering 50 angiotensin converting enzyme inhibitors 50 olaparib 50 Tekamlo 50 Erlotinib 50 doxorubicin HCl 50 Taxotere ® 50 anti arrhythmic drugs 50 pancreatic neuroendocrine tumors 50 abacavir 50 fluconazole 50 paroxetine Paxil 50 BCG refractory 50 grade gliomas 50 RCTs 50 pentamidine 50 inhaled corticosteroid 50 rifabutin 50 BAY #-# 50 statins 50 valopicitabine 50 deferoxamine 50 argatroban 50 potassium sparing diuretics 50 abacavir Ziagen 50 Pemetrexed 50 HBV vaccine 50 polypharmacy 50 posttransplant 50 pharmacological interventions 50 antipsychotic medications 50 steroid dexamethasone 50 active antiretroviral therapy 50 antibiotic amoxicillin 50 IV tPA 50 octreotide 50 LEP ETU 50 VFEND 50 Hodgkin lymphoma HL 50 Bezielle 50 nucleotide analogues 50 CR# vcMMAE 50 ZOLINZA 50 colorectal liver metastases 50 Exforge HCT 50 Aptivus 50 randomized clinical trials 50 liver transplant recipients 50 surgical debulking 50 erythropoietic agents 50 oritavancin 50 Antipsychotic medications 50 Vidaza azacitidine 50 Symbicort SMART 50 KETEK 50 de novo kidney transplant 50 reperfusion therapy 50 Interferon alpha 50 HIV protease inhibitors 50 interventional therapies 50 triptans 50 investigational therapies 50 TYGACIL 50 anticonvulsant drugs 50 baminercept 50 beta blocker atenolol 50 Golimumab 50 REYATAZ ® 50 treprostinil 50 beta interferons 50 Smac mimetics 50 ABVD 50 haloperidol Haldol 50 chronic HCV genotype 50 immunosuppressant drug 50 sodium stibogluconate 50 hypofractionated radiation 50 TNF alpha inhibitors 50 cardiovascular morbidity 50 myeloablative 50 INFERGEN 50 VIRAMUNE 50 metastatic colon cancer 50 topical NSAIDs 50 Perforomist ™ Inhalation Solution 50 intraperitoneal chemotherapy 50 FROVA 50 tirofiban 50 virological response 50 allogeneic transplant